Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham CorpfiledCriticalSmithKline Beecham Corp
Priority to ES9300107ApriorityCriticalpatent/ES2068739B1/es
Publication of ES2068739A1publicationCriticalpatent/ES2068739A1/es
Application grantedgrantedCritical
Publication of ES2068739B1publicationCriticalpatent/ES2068739B1/es
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur
(AREA)
Abstract
INHIBIDORES RETROVIRALES DE PROTEASAS. ESTOS COMPUESTOS TIENEN LA FORMULA FORMULA EN DONDE RBS1 SC, RBS2 SC, RBS3 SC, RBS4 SC Y RBS5 SC SIGNIFICAN DIVERSOS RADICALES ORGANICOS O INORGANICOS. SE UTILIZAN PARA EL TRATAMIENTO DE ENFERMEDADES RETROVIRALES, INCLUYENDO EL TRATAMIENTO DE ESTADOS DE ENFERMEDAD ASOCIADOS CON VIRUS DE LA INMUNODEFICIENCIA HUMANA (HIV-1, HIV-II).
ES9300107A1993-01-211993-01-21Inhibidores retrovirables de proteasas.
Expired - Fee RelatedES2068739B1
(es)
Compuestos inhibidores de la proteasa del virus dela inmunodeficiencia humana, procedimiento para supreparacion y formulacion farmaceutica que los contiene.